Newsroom

Sorted by: Latest

-

Gustave Roussy et One Biosciences s'associent pour intégrer les technologies en cellule unique dans la pratique clinique au service de l'oncologie de précision

PARIS--(BUSINESS WIRE)--Gustave Roussy s'associe à One Biosciences, une techbio qui exploite la technologie en cellule unique (single cell) et l'intelligence artificielle pour développer des diagnostics de précision. Cette collaboration vise à démontrer plus avant la faisabilité et l'impact d’intégrer l'analyse transcriptomique en cellule unique dans le parcours de soins des patients. Gustave Roussy, premier centre de lutte contre le cancer en Europe, s'allie à One Biosciences pour exploiter le...
-

Gustave Roussy and One Biosciences Partner to Bring Single Cell to Clinical Practice for Precision Oncology

PARIS--(BUSINESS WIRE)--Gustave Roussy and One Biosciences announce partnership to bring single cell to clinical practice for precision oncology....
-

FiscalNote Expands PolicyNote API, Adding Local Government Intelligence to Enterprise and AI Agent Workflows

WASHINGTON--(BUSINESS WIRE)--FiscalNote Expands PolicyNote API, Adding Local Government Intelligence to Enterprise and AI Agent Workflows...
-

InterSystems IntelliCare Becomes the First AI-Native EHR to Achieve EU Medical Device Regulation Certification

BOSTON--(BUSINESS WIRE)--InterSystems, a creative data technology provider powering more than one billion health records globally, today announced that its electronic health record (EHR) solutions have been certified as Class IIa Medical Devices under Regulation (MDR) certification under Regulation (EU) 2017/745. This approval marks the first fully unified AI-native EHR to achieve MDR Class IIa certification in the European Union. This certification demonstrates that InterSystems AI-native EHR...
-

Matternet and Amprius Partner to Advance Drone Delivery

MOUNTAIN VIEW, Calif.--(BUSINESS WIRE)--Matternet, the world’s only FAA Type Certified drone delivery company, and Amprius Technologies, Inc., a leader in advanced lithium-ion batteries, today announced a strategic collaboration to advance the performance and economics of autonomous aerial delivery through high-energy density silicon anode cells. Amprius cells are now deployed in Matternet’s M2 aircraft, and the companies are extending their work to battery solutions optimized for Matternet's n...
-

Eris SOFR Swap Futures Open Interest Triples Ahead of June Eris Options Launch, New Funding Round

CHICAGO--(BUSINESS WIRE)--Eris Innovations, an intellectual property licensing company and the creator of Eris SOFR Swap futures (Eris SOFR), today announced a new investment round backed by leading trading firms, following a marked rise in Eris SOFR activity at CME Group. Eris Innovations completed the investment round to support the launch of Eris Options in June, as well as the continued growth of the Eris SOFR complex, providing capital and strategic alignment with core liquidity providers....
-

NatureSweet® Introduces Golden Cherubs®: Everything You Love, Now in Gold

SAN ANTONIO--(BUSINESS WIRE)--NatureSweet® Introduces Golden Cherubs®: New golden grape tomato delivers the perfect balance of sweetness and zesty flavor....
-

InterSystems IntelliCare wordt het eerste AI-native EPD dat de EU-certificering voor medische hulpmiddelen behaalt

BOSTON--(BUSINESS WIRE)--InterSystems, een leverancier van creatieve datatechnologie die wereldwijd meer dan een miljard medische dossiers voedt, heeft vandaag aangekondigd dat zijn oplossingen voor elektronische medische dossiers (EHR) zijn gecertificeerd als Klasse IIa Medische Hulpmiddelen onder Verordening (MDR) certificering onder Verordening (EU) 2017/745. Deze goedkeuring markeert de eerste volledig uniforme AI-native EHR die MDR Klasse IIa certificering behaalt in de Europese Unie. Deze...
-

Verici Dx Announces Publication Validating Pre-Transplant Gene Signature Test for Predicting Early Acute Rejection in Kidney Transplant Recipients

FRANKLIN, Tenn.--(BUSINESS WIRE)--Verici Dx plc (AIM: VRCI), a developer of advanced clinical diagnostics for organ transplant, today announced the publication of a peer-reviewed clinical validation study of the Pre-Transplant Rejection Assessment (PTRA) test that stratifies patients undergoing deceased donor kidney transplantation as to their risk of acute rejection in the first two months post-transplant. The study, entitled “A Pre-Kidney Transplant Blood-Based Next-Generation Sequencing Assa...
-

Redwire Awarded a Multi-Year Contract to Deliver Next Generation Penguin Mk3 Tactical UAS to NATO Country

JACKSONVILLE, Fla.--(BUSINESS WIRE)--Redwire Corporation (NYSE: RDW), a global leader in space and defense technology solutions, today announced that it has been awarded a multi-year contract valued at high eight-figures, through a competitive tender, by an undisclosed NATO country ally to deliver its Penguin Mk3 uncrewed aerial system (UAS) as part of a multi-year modernization program for the country’s tactical UAS capabilities. Redwire’s Penguin series UAS is fielded globally and is recogniz...